Scientists Advancing Affordable Medicines, Inc. is a nonprofit 501(c)(6) organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. Because we are sharing approaches now for the affordable medicines of tomorrow, we have adopted the tradename SAAMnow.
VAM Week 2021 - Value Added Medicines
SAAMnow is partnering with The 505(b)(2) Platform to host a virtual event October 25-29, 2021.
Why Should You Attend:
This virtual conference is fully dedicated to furthering the understanding of Value Added Medicine development, approval and commercialization. Hear from and interact with speakers from the FDA, Industry and Suppliers as they discuss important topics and areas in the development, approval and commercialization of medications utilizing FDA's 505(b)(2) Pathway.
SAAMnow offers individuals the opportunity to potentially impact the availability of affordable medicines through cutting-edge research. SAAMnow is looking for individuals involved/interested in research & development, formulation/manufacturing science, analytical chemistry, clinical science, statistics, quality systems, regulatory science, marketing, and allied disciplines associated with the development, manufacturing, testing, and commercialization of high quality affordable medicines. Affordable medicines are broadly defined as those that take advantage of abbreviated regulatory filing pathways, resulting in development cost savings that can then be passed on to patients. Examples include conventional generic pharmaceuticals, biosimilars, and products filed via hybrid regulatory pathways, such as the 505(b)(2) route.
Our annual membership dues: $100.